Spoken Alpha · Executive

Kelly Blackburn

EVP, Clinical DevelopmentCRVOCervoMed Inc.

Current

Tracked since Feb 11, 2026

No earnings-call appearances indexed yet.

Role timeline

CRVOCervoMed Inc.
Current
EVP, Clinical Development
Feb 11, 2026 – Present · source: edgar_form4
CRVOCervoMed Inc.
SVP, Clinical Development
Jan 26, 2024 – Feb 4, 2025 · source: edgar_form4
CRVOCervoMed Inc.
VP, Clinical Development
Aug 16, 2023 – Sep 15, 2023 · source: edgar_form4
ATYRaTYR PHARMA INC
VP, Clinical Affairs
Oct 1, 2015 – Mar 28, 2016 · source: edgar_form4
ATYRaTYR PHARMA INC
See Remarks
May 6, 2015 – May 6, 2015 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

No earnings-call appearances indexed for this executive yet.